+44 115 974 9000
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world
We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Upcoming webinar with Nikki Whitfield, VP, CDMO Services and Gabor Heltovics, CEO, #DRGT on April 24— Quotient Sciences (@Quotient_Sci) March 27, 2019
Title: Accelerating drug product development from early phase to scale up and commercialisation.
Register here: https://t.co/TwbeUFoOoR #DrugDevelopment #EarlyPhase #CDMO pic.twitter.com/gBCwLCX0JW
Our VP - CDMO, Nikki Whitfield will be presenting and chairing a stream at @FDDCongress 5th annual event in London from 29-30 April.— Quotient Sciences (@Quotient_Sci) March 19, 2019
More info: https://t.co/8YkI2JbwCJ#DrugDevelopment #CDMO #Pharma #BioTech #PharmaServices #Formulation #SmallMolecule #OxfordGlobal pic.twitter.com/OidLVCglTW